U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P37231|||Q15179
Gene ID: 5468.0
Gene Symbol: PPARG
Target Organism: Homo sapiens (Human)
Target ID: Q92633
Gene ID: 1902.0
Gene Symbol: LPAR1
Target Organism: Homo sapiens (Human)
10.0 µM [IC50]
Target ID: Q9HBW0
Gene ID: 9170.0
Gene Symbol: LPAR2
Target Organism: Homo sapiens (Human)
5.5 µM [IC50]
Target ID: Q9UBY5
Gene ID: 23566.0
Gene Symbol: LPAR3
Target Organism: Homo sapiens (Human)
3.1 µM [IC50]
Substance Class Mixture
Created
by admin
on Wed Apr 02 05:00:32 GMT 2025
Edited
by admin
on Wed Apr 02 05:00:32 GMT 2025
Record UNII
1RXS4UE564
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALTEPLASE
INN   MART.   USAN   USP   VANDF   WHO-DD  
INN   USAN  
Official Name English
ALTEPLASE (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
ALTEPLASE [MART.]
Common Name English
ALTEPLASE [USAN]
Common Name English
ALTEPLASE FOR INJECTION
EP  
Common Name English
alteplase [INN]
Common Name English
ALTEPLASE (GENETICAL RECOMBINATION) [JAN]
Common Name English
ALTEPLASE [VANDF]
Common Name English
TISSUE PLASMINOGEN ACTIVATOR, RECOMBINANT
Common Name English
ALTEPLASE FOR INJECTION [EP MONOGRAPH]
Common Name English
ACTIVASE
Brand Name English
ACTILYSE
Brand Name English
ALTEPLASE [JAN]
Common Name English
ALTEPLASE, RECOMBINANT
Common Name English
ALTEPLASE [PURPLE BOOK CDER]
Common Name English
EC 3.4.21.68
Common Name English
RT-PA
Code English
PLASMINOGEN ACTIVATOR (HUMAN TISSUE-TYPE PROTEIN MOIETY)
Common Name English
TISSUE PLASMINOGEN ACTIVATOR ALTEPLASE
MI  
Common Name English
TPA
Common Name English
ALTEPLASE [USP MONOGRAPH]
Common Name English
Alteplase [WHO-DD]
Common Name English
ALTEPLASE,RECOMBINANT [VANDF]
Common Name English
TISSUE PLASMINOGEN ACTIVATOR ALTEPLASE [MI]
Common Name English
ALTEPLASE,RECOMBINANT
VANDF  
Common Name English
Classification Tree Code System Code
WHO-VATC QB01AD02
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
FDA ORPHAN DRUG 163502
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
FDA ORPHAN DRUG 331410
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
WHO-ATC B01AD02
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
FDA ORPHAN DRUG 431414
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
WHO-ATC S01XA13
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
WHO-VATC QS01XA13
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
NCI_THESAURUS C29750
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
Code System Code Type Description
LACTMED
Alteplase
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
DRUG CENTRAL
5141
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201593
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
DAILYMED
1RXS4UE564
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
EVMPD
SUB32223
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
WIKIPEDIA
Alteplase
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
EVMPD
SUB126952
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
RXCUI
8410
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY RxNorm
DRUG BANK
DB00009
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
EVMPD
SUB05378MIG
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
SMS_ID
100000089921
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
FDA UNII
1RXS4UE564
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
NCI_THESAURUS
C39607
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
USAN
X-35
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
IUPHAR
4985
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
INN
5975
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
MESH
D010959
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
MERCK INDEX
m10894
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY Merck Index
CAS
105857-23-6
Created by admin on Wed Apr 02 05:00:32 GMT 2025 , Edited by admin on Wed Apr 02 05:00:32 GMT 2025
PRIMARY
All of the following components must be present:
Related Record Type Details
SUBSTRATE->ENZYME
TARGET->ENZYME
SUBSTRATE->ENZYME
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
Definition References